Stealth Bio

Mighty Therapeutics

This company develops mitochondrial-targeted therapies for patients with rare genetic conditions like Barth syndrome and common age-related diseases.

Bitrobius

This company develops synthetic gene transfer technology to deliver DNA to cells for the treatment of genetic diseases and mitochondrial disorders.

Abliva

This biopharmaceutical company develops novel medicines for patients suffering from rare and severe primary mitochondrial diseases.

Immitra Bio

This company develops an in-vivo gene editing platform to provide off-the-shelf curative treatments for patients with rare genetic diseases.

Paeanbio

The company develops mitochondria-based biopharmaceuticals and cell therapies to treat inflammatory, autoimmune and oncology patients.

IMEL Biotherapeutics

This company develops mitochondrial replacement cell therapies for patients with genetic mitochondrial disorders and age-related diseases.

Reneo Pharmaceuticals

The company develops therapies for patients with rare genetic mitochondrial diseases that cause deficits in cellular metabolism and energy production.

MitoImmune Therapeutics

This biotechnology firm develops mitochondrial-targeted therapies for patients with inflammatory and rare diseases, including cancer treatment side effects like oral mucositis.